Innobio Corporation Limited
Is this your company? Claim this profile
Excipients & Specialty Ingredients
Company Overview
About
Innobio Corporation Limited is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Neurology
Quick Facts
HQ:China
Founded:2016
Employees:2,728
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval L272XN
Health Canada · #APR-B27RXIAR · 2018-03-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-3LYLXT7Q
Issued: 2020-10-26
Expires: 2025-09-03
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-J01WGLHQ
Issued: 2020-04-22
Expires: 2025-12-04
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-RAMMAYLK
Issued: 2020-01-15
Expires: 2025-06-10
Loading CDMO intelligence...
Key facts about Innobio Corporation Limited
- Innobio Corporation Limited is headquartered in China.
- Innobio Corporation Limited was founded in 2016.
- Innobio Corporation Limited has 2,728 employees.
- Innobio Corporation Limited's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Innobio Corporation Limited
Directory pages this company appears in, each with the full list of matching manufacturers.